Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Olivier Boucherat, Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Charifa Awada, Tsukasa Shimauchi(Kyushu University), Wenhui Wu(Shanghai Pulmonary Hospital), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec)
Cited by 13
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy
|JCI Insight|2017|66
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
|American Journal of Respiratory and Critical Care Medicine|2020|34
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes
|Science Translational Medicine|2024|33